
    
      Experimental intervention (6 weeks + duration of the control intervention):

      2 x N8 cycle (topotecan, cyclophosphamide, and etoposide) followed by standard arm treatment
      (i.e., control intervention)

      Control intervention (total duration 70-76 weeks):

      3 x N5 cycle (cisplatin, etoposide, and vindesine) 3 x N6 cycle (vincristine, dacarbacine,
      ifosfamide, and doxorubicine), myeloablative chemotherapy with autologous stem cell
      transplantation (melphalan, carboplatin, etoposide) 9 x retinoic acid cycles (6 months, 3
      months break, 3 months) supportive care (PCP/fungal prophylaxis, transfusions, antibiotics,
      G-CSF)
    
  